Drugs
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 01/28/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 01/28/15 -- (NASDAQ: CBLI) today announced the appointment of Elena Kasimova of BioProcess Capital Partners to the Company's Board of Directors. Ms. Kasimova was ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 01/28/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 01/26/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 01/22/15 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly owned subsidiaries ("Knight"), announced today that it has entered into a se ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 01/21/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight") announced today (i) the resignation of Hillel Rosen and (ii) the appointment Ed Schutter to ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/15/15 -- A correction from source is being issued for the Canadian Cannabis Corp. release that was disseminated on January 13, 2015 at 16:35 ET. In the first ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 01/15/15 -- Flamel Technologies (NASDAQ: FLML) today announced that the Wholesale Acquisition Cost (WAC) for Bloxiverz has been increased to $98.75 per vial for both ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/14/15 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/13/15 -- Canadian Cannabis Corp. ("CCAN" or the "Company") (OTCQB: CCAN) is pleased to announce the appointment of Mr. Richard Wachsberg t ...
TORONTO, ON: TORONTO, ON -- (Marketwired) -- 01/12/15 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces due diligence update with the disclosure of total number of plants, strains and current dispensaries ...
SOUTH SAN FRANCISCO, CA: California Statesman Brings More Than 50 Years of Broad-Ranging Experience to Support Development of Groundbreaking Treatment for Sickle Cell Disease ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/07/15 -- Canadian Cannabis Corp. ("CCAN" or "The Company") (OTCQB: CCAN), is pleased to announce that it has entered into a Letter of Inte ...
LOUISVILLE, CO: AB101 Positioned to Be the First Once-Weekly Basal Insulin for Diabetes Patients ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/06/15 -- (OTCBB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing i ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 01/06/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reconfirmed its anticipated year-end 2014 revenue and non-GAAP earnings per share (EPS) guidance, a ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/05/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today, through its U.S. opera ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 01/05/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/05/15 -- Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel small molecule therapeutics for the treatment of severe blood dis ...
BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 01/05/15 -- Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, d ...
